Other recent publications have also implicated a role for Grem1 in regulating epithelial-mesenchymal transition24 and lineage plasticity through direct activation of the fibroblast growth factor receptor 125 in pancreatic cancer and prostate cancer, respectively. Here, GREM1 is linked to pancreatic neoplasm.